Group Action Lawyers
Latest News & Updates

Category: Medicines

personal injury litigation for multiple victims
January 27, 2026
Personal Injury Litigation for Multiple Victims: Your Path to Justice with The Group Action Lawyers

The Group Action Lawyers specialises in personal injury litigation for multiple victims, guiding affected individuals through the complexities of group action claims to secure fair compensation.

When multiple individuals suffer harm due to the same incident, such as a defective product, environmental disaster, or corporate negligence, pursuing justice as a group can be a powerful approach.

This article explores the essentials of group action lawsuits, their benefits, and how our experienced legal team can help you navigate this process.

Continue Reading…

100% commitment to group actions
January 20, 2026
100% Commitment to Group Actions: Your Path to Compensation with The Group Action Lawyers

The Group Action Lawyers specialises in guiding clients through the process of collective legal claims with a 100% commitment to group actions, ensuring your voice is heard and your rights are protected.

When individuals face harm or injustice from large organisations, joining forces in a group action can be a powerful way to seek justice and compensation. This article explores what group actions are, their benefits, and how our dedicated team can help you navigate the process to achieve the compensation you deserve.

Continue Reading…

mass compensation for dangerous drug
January 13, 2026
Securing Mass Compensation for Dangerous Drug Victims Through Group Actions

Pharmaceutical negligence can devastate lives, but victims no longer need to fight alone. The Group Action Lawyers specialises in uniting affected individuals to pursue mass compensation for dangerous drug cases via powerful group actions.

This article explains how these claims work, who qualifies, and why joining forces can maximise your chances of justice. With rising reports of unsafe medications—from contaminated batches to hidden long-term risks—group litigation has become a vital tool for accountability and recovery.

Continue Reading…

standards and regulations around cosmetic procedures
November 11, 2025
Understanding Standards and Regulations Around Cosmetic Procedures

In the wake of growing concerns over the safety and oversight of aesthetic treatments, the UK Parliament’s Women and Equalities Committee (WEC) has been actively scrutinising the industry. This inquiry highlights critical issues in standards and regulations around cosmetic procedures, shedding light on how lapses can lead to serious health impacts.

As specialists in collective legal claims, The Group Action Lawyers is here to help those affected pursue justice through group actions, where multiple claimants join forces for stronger representation and potential compensation.

Continue Reading…

incorrect dose content statement
October 28, 2025
Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall

A recall of Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.

The Group Action Lawyers specialises in helping affected individuals pursue compensation through group actions when pharmaceutical errors like this occur. This article explores the details of the recall and how people might be eligible to generally claim compensation in such circumstances.

Continue Reading…

patient information leaflet problems
August 26, 2025
Patient Information Leaflet Problems: Your Right to Compensation

Failure in the patient information leaflet problems can potentially endanger countless patients who depend on medications for treatment.

In May 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued a critical Class 4 Medicines Notification concerning multiple topical steroid products manufactured by Chemidex Pharma Ltd. The core issue lies in the patient information leaflets (PILs) included with these medications, which reportedly omitted vital safety information about potential side effects, specifically visual disturbances such as blurred vision or other ocular complications.

The absence of accurate information in patient information leaflets can have far-reaching consequences, as patients rely on these documents to understand the risks associated with their medications.

Continue Reading…

deadlines to claim Mercedes emissions compensation
November 07, 2023
Deadlines to Claim Mercedes Emissions Compensation: Join the Group Action Now

As the deadlines to claim Mercedes emissions compensation approach, it is imperative to act swiftly if you have been affected by this issue.

At The Group Action Lawyers, we have been tirelessly working to ensure our clients are included in the court action. In this article, we can provide you with essential information on the deadlines, the group action process, and why it is imperative to join now.

Continue Reading…

medical device incompatibility
October 17, 2023
Compensation in a Medical Device Incompatibility Group Action

Medical device incompatibility issues can cause considerable problems for patients and could even lead to harm if something goes wrong.

At The Group Action Lawyers, we understand that when medical devices fail to function as intended, it can lead to serious health risks and complications for patients. In this article, we will delve into the concept of medical device incompatibility and discuss how individuals could be eligible to claim compensation through group actions in some cases. We will also touch on a real example from an alert issued by UK regulators.

Continue Reading…

Sabril tablets and granules
October 10, 2023
Sabril Tablets and Granules Concerns Raised

Potential concerns that have arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.

The medications, manufactured by Aventis Pharma Limited (a subsidiary of Sanofi), have reportedly been subject to advice issued by The Medicines and Healthcare products Regulatory Agency (MHRA). The regulator has covered the issue of a precautionary recall for Sabril 500 mg film-coated tablets and Sabril 500 mg granules for oral solution (EL 23/A25).

Continue Reading…

NHS group actions
June 20, 2023
NHS group actions: compensation claiming

NHS group actions can be claims for compensation arising from events of negligence where multiple people have been affected and where we can represent individuals for claims.

Common examples can include privacy breaches or medical negligence and product liability cases. We have vast experience in all these areas of law, and the best place to start is to contact our team for free, no-obligation legal advice here now.

Continue Reading…